Status | Study |
Active, not recruiting |
Study Name: Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe Condition: Kaposi Sarcoma (KS) HIV Date: 2013-01-07 Interventions: Other: KS structured clinical care training Eight primary care sites in Zimbabwe will receive structured |
Recruiting |
Study Name: A Study of Selumetinib in Patients With Kaposi's Sarcoma Condition: AIDS-related Kaposi's Sarcoma Date: 2012-08-17 Interventions: Drug: Selumetinib The treatment schedule requires selumeti |
Recruiting |
Study Name: Pomalidomide for Kaposi Sarcoma in People With or Without HIV Condition: Kaposi Sarcoma Sarcoma, Kaposi Date: 2011-12-16 Interventions: Drug: Pomalidomide 5 mg p.o. for 21 of 28 days |
Terminated |
Study Name: A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma Condition: Kaposi Sarcoma Date: 2011-08-08 Interventions: Drug: everolimus everolimus per os 10mg per day |
Completed |
Study Name: Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity Condition: Kaposi´s Sarcoma Date: 2011-02-15 Interventions: Drug: Bevacizumab Intralesional bevacizumab, dosis of 5mg/cm2, injections every 2 weeks, total number of |
Completed |
Study Name: Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) Condition: Kaposi's Sarcoma Date: 2010-12-20 Interventions: Drug: Maraviroc FDA Recommended dosing will be used in thi |
Completed |
Study Name: Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma Condition: Kaposi's Sarcoma Date: 2010-02-10 Interventions: Drug: Indinavir in association with Vinblastina +/- Bleomicina Treatment consists in an induction phase |
Completed |
Study Name: Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma Condition: AIDS-Related Kaposi Sarcoma Recurrent Kap Date: 2010-01-26 Interventions: Drug: Lenalidomide Lenalidomide is administered daily on days 1-21 of a 28-day cycle. The maximum durati |
Completed |
Study Name: A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe Condition: AIDS-related Kaposi's Sarcoma Date: 2009-02-02 Interventions: Drug: abacavir/3TC/zidovudine |
Terminated |
Study Name: PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma Condition: Kaposi's Sarcoma Date: 2008-05-29 Interventions: Drug: VEGF inhibitor PTC299 20 |